Lorazepam Solution, Concentrate
Product Images NDC 0054-3532

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 0054-3532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (107e39a2 Bcfa 457f Bedf B465918e92d4 01)

Chemical structure of Lorazepam, showing its molecular framework with chlorine atoms and a fused benzodiazepine ring system.*

FDA Label Image

Label-2mg-ml-06.jpg (Label 2mg mL 06)

Lorazepam Oral Concentrate USP 2 mg per mL solution label for oral use. The 30 mL bottle label from Hikma Pharmaceuticals USA Inc. shows dosing instructions, storage temperature (2° to 8°C), usage directions with an oral syringe, and a warning to discard the bottle after 90 days. The label includes the NDC 0054-3532 and distributor West-Ward Pharmaceuticals Corp.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.